CoChat

High-throughput continuous-flow microfluidic electroporation of mRNA into primary human T cells for applications in cellular therapy manufacturing

Lissandrello, Charles A., Santos, Jose A., Hsi, Peter, Welch, Michaela, Mott, Vienna L., Kim, Ernest S., Chesin, Jordan, Haroutunian, Nerses J., Stoddard, Aaron G., Czarnecki, Andrew, Coppeta, Jonathan R., Freeman, Daniel K., Flusberg, Deborah A., Balestrini, Jenna L., Tandon, Vishal · 2020 · Scientific Reports
Cited by 82

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Implementation of gene editing technologies such as CRISPR/Cas9 in the manufacture of novel cell-based therapeutics has the potential to enable highly-targeted, stable, and persistent genome modifications without the use of viral vectors. Electroporation has emerged as a preferred method for delivering gene-editing machinery to target cells, but a major challenge remaining is that most commercial electroporation machines are built for research and process development rather than for large-scale, automated cellular therapy manufacturing. Here we present a microfluidic continuous-flow electrotransfection device designed for precise, consistent, and high-throughput genetic modification of target cells in cellular therapy manufacturing applications. We optimized our device for delivery of mRNA into primary human T cells and demonstrated up to 95% transfection efficiency with minimum impact on cell viability and expansion potential. We additionally demonstrated processing of samples comprising up to 500 million T cells at a rate of 20 million cells/min. We anticipate that our device will help to streamline the production of autologous therapies requiring on the order of 10$$^8$$ 8 –10$$^9$$ 9 cells, and that it is well-suited to scale for production of trillions of cells to support emerging allogeneic therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-020-73755-0

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 50

  1. Aijaz, A. et al. Biomanufacturing for clinically advanced cell therapies. Nat. Biomed. Eng. 2, 362–376. https://doi.org/10.1038/s41551-018-0246-6 (2018). · DOI · Paper page
  2. Kochenderfer, J. N. & Rosenberg, S. A. Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors. Nat. Rev. Clin. Oncol. 10, 267–276. https://doi.org/10.1038/nrclinonc.2013.46 (2013). · DOI · Paper page
  3. Marcucci, K. T. et al. Retroviral and lentiviral safety analysis of gene-modified T cell products and infused HIV and oncology patients. Mol. Ther. 26, 269–279. https://doi.org/10.1016/j.ymthe.2017.10.012 (2018). · DOI · Paper page
  4. Moore, N. et al. A microfluidic device to enhance viral transduction efficiency during manufacture of engineered cellular therapies. Sci. Rep. 9, 15101. https://doi.org/10.1038/s41598-019-50981-9 (2019). · DOI
  5. Stewart, M. P., Langer, R. & Jensen, K. F. Intracellular delivery by membrane disruption: Mechanisms, strategies, and concepts. Chem. Rev. 118, 7409–7531. https://doi.org/10.1021/acs.chemrev.7b00678 (2018). · DOI · Paper page
  6. Felgner, P. L. & Ringold, G. M. Cationic liposome-mediated transfection. Nature 337, 387–388. https://doi.org/10.1038/337387a0 (1989). · DOI · Paper page
  7. Buttgereit, P. et al. Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection. Cancer Gene Ther. 7, 1145–1155. https://doi.org/10.1038/sj.cgt.7700209 (2000). · doi:10.1038/sj.cgt.7700209
  8. Sharei, A. et al. A vector-free microfluidic platform for intracellular delivery. Proc. Natl. Acad. Sci. USA 110, 2082–2087. https://doi.org/10.1073/pnas.1218705110 (2013). · DOI · Paper page
  9. Meacham, J. M., Durvasula, K., Degertekin, F. L. & Fedorov, A. G. Physical methods for intracellular delivery: Practical aspects from laboratory use to industrial-scale processing. J. Lab. Autom. 19, 1–18. https://doi.org/10.1177/2211068213494388 (2014). · DOI · Paper page
  10. Jarrell, J. A. et al. Intracellular delivery of mRNA to human primary T cells with microfluidic vortex shedding. Sci. Rep. 9, 1–11. https://doi.org/10.1038/s41598-019-40147-y (2019). · DOI
  11. Kang, G. et al. Intracellular nanomaterial delivery via spiral hydroporation. ACS Nanohttps://doi.org/10.1021/acsnano.9b07930 (2020). · DOI
  12. Manuri, P. V. et al. PiggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies. Hum. Gene Ther. 21, 427–437. https://doi.org/10.1089/hum.2009.114 (2010). · DOI · Paper page
  13. Chang, L. et al. Micro-/nano-scale electroporation. Lab. Chiphttps://doi.org/10.1039/C6LC00840B (2016). · DOI
  14. Geng, T. & Lu, C. Microfluidic electroporation for cellular analysis and delivery. Lab Chip 13, 3803–21. https://doi.org/10.1039/c3lc50566a (2013). · DOI
  15. Rols, M. P. & Teissié, J. Electropermeabilization of mammalian cells to macromolecules: Control by pulse duration. Biophys. J. 75, 1415–1423. https://doi.org/10.1016/S0006-3495(98)74060-3 (1998). · DOI · Paper page
  16. Rowley, J., Abraham, E., Campbell, A., Brandwein, H. & Oh, S. Meeting lot-size challenges of manufacturing adherent cells for therapy. BioProcess Int. 10, 7 (2012).
  17. Depil, S., Duchateau, P., Grupp, S. A., Mufti, G. & Poirot, L. ‘Off-the-shelf’ allogeneic CAR T cells: Development and challenges. Nat. Rev. Drug Discov.https://doi.org/10.1038/s41573-019-0051-2 (2020). · DOI · Paper page
  18. Wei, Z. et al. A laminar flow electroporation system for efficient DNA and siRNA delivery. Anal. Chem. 83, 5881–5887. https://doi.org/10.1021/ac200625b (2011). · DOI
  19. Zhu, T. et al. Electroporation based on hydrodynamic focusing of microfluidics with low dc voltage. Biomed. Microdevices 12, 35–40. https://doi.org/10.1007/s10544-009-9355-z (2010). · doi:10.1007/s10544-009-9355-z
  20. Hsi, P. et al. Acoustophoretic rapid media exchange and continuous-flow electrotransfection of primary human T cells for applications in automated cellular therapy manufacturing. Lab Chip 19, 2978–2992. https://doi.org/10.1039/C9LC00458K (2019). · DOI
  21. Franks, W., Schenker, I., Schmutz, P. & Hierlemann, A. Impedance characterization and modeling of electrodes for biomedical applications. IEEE Trans. Biomed. Eng. 52, 1295–1302 (2005). · DOI · Paper page
  22. Rosazza, C., Meglic, S. H., Zumbusch, A., Rols, M.-P. & Miklavcic, D. Gene electrotransfer: A mechanistic perspective. Curr. Gene Ther. 16, 98–129. https://doi.org/10.2174/1566523216666160331130040 (2016). · DOI · Paper page
  23. Jaroszeski, M. J., Heller, R., Rols, M.-P. & Teissié, J. Flow cytometry quantification of electropermeabilization. Flow Cytom. Protocols 97, 141–148. https://doi.org/10.1385/0-89603-354-6:141 (2003). · doi:10.1385/0-89603-354-6:141
  24. Weaver, J. C. & Chizmadzhev, Y. Theory of electroporation: A review. Bioelectrochem. Bioenergetics 41, 135–160. https://doi.org/10.1016/S0302-4598(96)05062-3 (1996). · DOI · Paper page
  25. Liu, F. et al. Mechanism of in vivo DNA transport into cells by electroporation: Electrophoresis across the plasma membrane may not be involved. J. Gene Med. 8, 353–361. https://doi.org/10.1002/jgm.851 (2006). · doi:10.1002/jgm.851
  26. Escoffre, J. M. et al. What is (still not) known of the mechanism by which electroporation mediates gene transfer and expression in cells and tissues. Mol. Biotechnol. 41, 286–295. https://doi.org/10.1007/s12033-008-9121-0 (2009). · DOI · Paper page
  27. Wu, M. & Yuan, F. Membrane binding of plasmid DNA and endocytic pathways are involved in electrotransfection of mammalian cells. PLoS ONEhttps://doi.org/10.1371/journal.pone.0020923 (2011). · DOI · Paper page
  28. Chang, C. C., Wu, M. & Yuan, F. Role of specific endocytic pathways in electrotransfection of cells. Mol. Ther. Methods Clin. Dev. 1, 14058. https://doi.org/10.1038/mtm.2014.58 (2014). · DOI
  29. Cervia, L. D., Chang, C. C., Wang, L. & Yuan, F. Distinct effects of endosomal escape and inhibition of endosomal trafficking on gene delivery via electrotransfection. PLoS ONE 12, 1–18. https://doi.org/10.1371/journal.pone.0171699 (2017). · DOI · Paper page
  30. Mao, M. et al. Involvement of a Rac1-dependent macropinocytosis pathway in plasmid DNA delivery by electrotransfection. Mol. Ther. 25, 803–815. https://doi.org/10.1016/j.ymthe.2016.12.009 (2017). · DOI
  31. Sachdev, S. et al. DNA-membrane complex formation during electroporation is DNA size-dependent. Biochim. Biophys. Acta Biomembr. 1862, 183089 (2020). · DOI
  32. Van Meirvenne, S. et al. Efficient genetic modification of murine dendritic cells by electroporation with mRNA. Cancer Gene Ther. 9, 787–797. https://doi.org/10.1038/sj.cgt.7700499 (2002). · DOI
  33. Bernhardt, J. & Pauly, H. On the generation of potential differences across the membranes of ellipsoidal cells in an alternating electrical field. Biophysik 10, 89–98. https://doi.org/10.1007/BF01189915 (1973). · DOI
  34. Rols, M. P. & Teissié, J. Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon. Biophys. J. 58, 1089–1098. https://doi.org/10.1016/S0006-3495(90)82451-6 (1990). · DOI · Paper page
  35. Teissié, J. & Rols, M. P. An experimental evaluation of the critical potential difference inducing cell membrane electropermeabilization. Biophys. J. 65, 409–413. https://doi.org/10.1016/S0006-3495(93)81052-X (1993). · DOI · Paper page
  36. Schwan, H. P. Biophysics of the Interaction of Electromagnetic Energy with Cells and Membranes. Biological Effects and Dosimetry of Nonionizing Radiation 213–231, https://doi.org/10.1007/978-1-4684-4253-3_9 (Springer, US, Boston) (1983). · doi:10.1007/978-1-4684-4253-3_9
  37. Tieleman, D. P. The molecular basis of electroporation. BMC Biochem. 5, 1–12. https://doi.org/10.1186/1471-2091-5-10 (2004). · DOI · Paper page
  38. Gowrishankar, T. R., Esser, A. T., Vasilkoski, Z., Smith, K. C. & Weaver, J. C. Microdosimetry for conventional and supra-electroporation in cells with organelles. Biochem. Biophys. Res. Commun. 341, 1266–1276. https://doi.org/10.1016/j.bbrc.2006.01.094 (2006). · DOI · Paper page
  39. Hibino, M., Itoh, H. & Kinosita, K. Time courses of cell electroporation as revealed by submicrosecond imaging of transmembrane potential. Biophys. J. 64, 1789–1800. https://doi.org/10.1016/S0006-3495(93)81550-9 (1993). · DOI · Paper page
  40. Zheng, M., Shan, J. W., Lin, H., Shreiber, D. I. & Zahn, J. D. Hydrodynamically controlled cell rotation in an electroporation microchip to circumferentially deliver molecules into single cells. Microfluidics Nanofluidics 20, 1–12. https://doi.org/10.1007/s10404-015-1691-0 (2016). · DOI
  41. Velaga, S. et al. Clinical-grade regulatory T cells: Comparative analysis of large-scale expansion conditions. Exp. Hematol. 45, 27-35.e1. https://doi.org/10.1016/j.exphem.2016.09.008 (2017). · doi:10.1016/j.exphem.2016.09.008
  42. Hedfors, I. A. & Brinchmann, J. E. Long-term proliferation and survival of in vitro-activated T cells is dependent on interleukin-2 receptor signalling but not on the high-affinity IL-2R. Scand. J. Immunol. 58, 522–532. https://doi.org/10.1046/j.1365-3083.2003.01338.x (2003). · DOI
  43. Hinkson, I. V. & Elias, J. E. The dynamic state of protein turnover: It’s about time. Trends Cell Biol. 21, 293–303. https://doi.org/10.1016/j.tcb.2011.02.002 (2011). · DOI
  44. Mathieson, T. et al. Systematic analysis of protein turnover in primary cells. Nat. Commun. 9, 1–10. https://doi.org/10.1038/s41467-018-03106-1 (2018). · DOI · Paper page
  45. Aksoy, B. A., Wyatt, M. & Paulos, C. M. Human primary T cells: A practical guide. PeerJ Preprints 28, 1–31. https://doi.org/10.7287/peerj.preprints.26993v1 (2018). · doi:10.7287/peerj.preprints.26993v1
  46. Kochenderfer, J. N. et al. Allogeneic T cells that express an anti-CD19 chimeric antigen receptor induce remissions of B-cell malignancies that progress after allogeneic hematopoietic stem-cell transplantation without causing graft-versus-host disease. J. Clin. Oncol. 34, 1112–1121. https://doi.org/10.1200/jco.2015.64.5929 (2016). · DOI · Paper page
  47. Zhao, D. et al. A Flow-Through Cell Electroporation Device for Rapidly and Efficiently Transfecting Massive Amounts of Cells in vitro and ex vivo. Sci. Rep. 6, 18469. https://doi.org/10.1038/srep18469 (2016). · DOI
  48. Wang, S., Zhang, X., Wang, W. & Lee, L. J. Semicontinuous flow electroporation chip for high-throughput transfection on mammalian cells. Anal. Chem. 81, 4414–4421. https://doi.org/10.1021/ac9002672 (2009). · DOI
  49. Adamo, A., Arione, A., Sharei, A. & Jensen, K. F. Flow-through comb electroporation device for delivery of macromolecules. Anal. Chem. 85, 1637–1641. https://doi.org/10.1021/ac302887a (2013). · DOI · Paper page
  50. MacLeod, D. T. et al. Integration of a CD19 CAR into the TCR alpha chain locus streamlines production of allogeneic gene-edited CAR T cells. Mol. Ther. 25, 949–961. https://doi.org/10.1016/j.ymthe.2017.02.005 (2017). · DOI · Paper page

Cited by

See all 82

Metadata

Authors
Lissandrello, C. A., Santos, J. A., Hsi, P., Welch, M., Mott, V. L., Kim, E. S., Chesin, J., Haroutunian, N. J., Stoddard, A. G., Czarnecki, A., Coppeta, J. R., Freeman, D. K., Flusberg, D. A., Balestrini, J. L., & Tandon, V.
Venue
Scientific Reports
Published
2020-10-22
Volume
10
Issue
1
ISSN
2045-2322
Cited by
82
References
14
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High-throughput continuous-flow microfluidic electroporation of mRNA into primary human T cells for applications in cellular therapy manufacturing. https://app.cochat.ai/papers/10.1038/s41598-020-73755-0
The paper
Lissandrello, C. A., Santos, J. A., Hsi, P., Welch, M., Mott, V. L., Kim, E. S., Chesin, J., Haroutunian, N. J., Stoddard, A. G., Czarnecki, A., Coppeta, J. R., Freeman, D. K., Flusberg, D. A., Balestrini, J. L., & Tandon, V. (2020). High-throughput continuous-flow microfluidic electroporation of mRNA into primary human T cells for applications in cellular therapy manufacturing. Scientific Reports. https://doi.org/10.1038/s41598-020-73755-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.